Infectious complications in HIV-infected kidney transplant recipients. 2018

O Ailioaie, and N Arzouk, and M A Valantin, and J Tourret, and R O Calin, and M Turinici, and G Mircescu, and B Barrou
1 Renal Transplant Department, 26933 Pitié-Salpêtriere Hospital , Paris, France.

Renal transplantation is now a viable alternative for dialysis in HIV-infected patients who achieve good immunovirological control with current antiretroviral therapy regimens available. However, there are few studies that analyze the incidence of post-transplant infections in this population. In this study, a retrospective analysis of data files of 24 HIV-infected kidney transplant (KT) recipients was undertaken, matched to 21 non-infected controls. All patients received induction with anti-interleukin-2 antibodies and were followed in the Pitié-Salpêtrière Hospital in Paris, France. The rate of incidence of post-transplant infections was 23.58 and 26.98/100 patient-years, in HIV-infected and HIV-negative groups (relative risk [RR]: 0.90; 95% confidence interval [CI]: 0.58-1.39; p = 0.63). In HIV-infected KT recipients, bacterial infections were the most frequent (67.7%), followed by viral (14.7%) and fungal and parasitic infections (8.8%). Similar trends were seen in the control group. Incidence of opportunistic infections was similar in HIV-infected KT recipients and controls (38.2 vs. 26.5%; p = 0.44). There were three post-transplant HIV reactivations in two patients, secondary to poor adherence to medication. HIV status did not influence survival, but infections increased the risk of unfavorable outcome. Incidence of post-transplant infections was similar in HIV-infected KT recipients and controls. Infections, but not HIV status, had adverse effects on patient and graft survival.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

O Ailioaie, and N Arzouk, and M A Valantin, and J Tourret, and R O Calin, and M Turinici, and G Mircescu, and B Barrou
August 2021, Transplantation,
O Ailioaie, and N Arzouk, and M A Valantin, and J Tourret, and R O Calin, and M Turinici, and G Mircescu, and B Barrou
January 2009, Enfermedades infecciosas y microbiologia clinica,
O Ailioaie, and N Arzouk, and M A Valantin, and J Tourret, and R O Calin, and M Turinici, and G Mircescu, and B Barrou
January 2022, Frontiers in nephrology,
O Ailioaie, and N Arzouk, and M A Valantin, and J Tourret, and R O Calin, and M Turinici, and G Mircescu, and B Barrou
January 2005, Transplantation proceedings,
O Ailioaie, and N Arzouk, and M A Valantin, and J Tourret, and R O Calin, and M Turinici, and G Mircescu, and B Barrou
January 2005, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
O Ailioaie, and N Arzouk, and M A Valantin, and J Tourret, and R O Calin, and M Turinici, and G Mircescu, and B Barrou
July 2006, Advances in chronic kidney disease,
O Ailioaie, and N Arzouk, and M A Valantin, and J Tourret, and R O Calin, and M Turinici, and G Mircescu, and B Barrou
April 2000, Advances in renal replacement therapy,
O Ailioaie, and N Arzouk, and M A Valantin, and J Tourret, and R O Calin, and M Turinici, and G Mircescu, and B Barrou
January 2005, Transplantation proceedings,
O Ailioaie, and N Arzouk, and M A Valantin, and J Tourret, and R O Calin, and M Turinici, and G Mircescu, and B Barrou
September 1973, Transplantation proceedings,
O Ailioaie, and N Arzouk, and M A Valantin, and J Tourret, and R O Calin, and M Turinici, and G Mircescu, and B Barrou
June 1980, Southern medical journal,
Copied contents to your clipboard!